LIFEPAK 15 monitor/defibrillator
Physio-Control, Inc. · Decision date Sep 10, 2026
What did the FDA decide?
The FDA record for P160026/S073 describes the LIFEPAK® 15 monitor/defibrillator, product code MKJ, filed by Physio-Control, Inc., as an OK30 supplement. The stated purpose is a 30-Day Notice for a process change, specifically "removal of an incoming inspection process step." The supplement type is characterized as involving a manufacturer, sterilizer, packager or supplier.
The identifier P160026 establishes a relationship to the original PMA for this device, but the record does not describe the full original approval scope or which incoming inspection step was removed. It also does not identify the component or material affected, the rationale, or any verification data supporting the change. The reported purpose of this manufacturing notice does not establish safety or clinical effectiveness, and the entry provides no information beyond the descriptive fields.
FDA approval order statement
removal of an incoming inspection process step
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 10, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160026/S073
- Regulatory pathway
- PMA supplement
- Applicant
- Physio-Control, Inc.
- Product code
- MKJ
- Decision code
- OK30
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- Physio-Control, Inc.
- Product code
- MKJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160026. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160026 · Original PMA
LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE
P160026/S073 received
Application receipt date recorded by FDA.
P160026/S069 · Related supplement
LIFEPAK 35 monitor/defibrillator
P160026/S073 · FDA decision
30-Day Notice
P160026/S074 · Related supplement
LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE
P160026/S076 · Related supplement
LIFEPAK 35 monitor/defibrillator
Timeline entries are records held by MedtechLedger for P160026. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160026
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Physio-Control, Inc. | PMA approval | Jul 2, 2018 | FDA | |
LIFEPAK 35 monitor/defibrillatorP160026/S069 | Physio-Control, Inc. | PMA supplement | Sep 2, 2026 | FDA |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| ZOLL MEDICAL CORPORATION | PMA approval | Dec 27, 2017 | FDA | |
| ZOLL MEDICAL CORPORATION | PMA approval | May 26, 2017 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Physio-Control, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 11811 Willows Rd. NE, Redmond, WA, 98052
Sources and methodology
- Original FDA record: P160026/S073
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



